The glucose infusion rate of parenteral nutrition in the first week of life in preterm infants: an observational study

Table 5 Risk Factor for Mortality (n = 17)

Variables	n (%)	OR	95% CI	p
Group I	1 (5.9)	0.271	0.033–2.205	0.194
Group II	13 (76.5)	1.565	0.465–5.271	0.467
Group III	3 (17.6)	2.643	0.590–11.833	0.190
RDS	14 (82.4)	5.423	1.446–20.346	0.006*
NEC	2 (11.8)	1.390	0.263–7.363	0.691
Sepsis	9 (52.9)	3.875	1.306–11.495	0.011*
ROP	1 (5.9)	0.493	0.058–4.174	0.509
Pulmonary hypertension	3 (17.6)	2.643	0.590–11.833	0.190
Hypoglycemia	5 (29.4)	1.667	0.513–5.415	0.392
Hyperglycemia	2 (11.8)	0.836	0.168–4.171	0.827

Note: GIR, glucose infusion rate (mg/kg/min); Group I, the GIR usage of 5- < 7 g/kg/day; Group II, the GIR usage of 7–13 g/kg/day; Group III, the GIR usage of > 13–15 g/kg/day; RDS, respiratory distress syndrome; NEC, necrotizing enterocolitis; ROP, retinopathy of prematurity; OR, odds ratio; CI, confidence interval; *Significant p-value < 0.05

ISSN: 1824-7288